Late-Breaking Clinical Trial Data Underscore Safety And Efficacy Of Boston Scientific S-ICD System | BioSpace
BostonSci Cardiology on Twitter: "CHAMPION-AF is Boston Scientific's 5th #LAAC randomized controlled trial vs. pharmacotherapy, adding to nearly 20 years of clinical leadership. Learn more about how this trial seeks to expand
Jennie Tedrow - Senior Manager, Clinical Data Management - Boston Scientific | LinkedIn
BostonSci Cardiology on Twitter: "Boston Scientific has received full FDA IDE approval and CMS reimbursement for the CHAMPION-AF clinical trial. Learn more about the largest #LAAC device trial here: https://t.co/lMsxlO63Ky https://t.co/lLw7WRHpQJ" /
Getting to the heart of Boston Scientific's peripheral business; How Hologic sees trials changing | DeviceTalks
Investigator-Sponsored Research Program - Boston Scientific
EVOLVE & EVOLVE II Clinical Trial Results - Boston Scientific
Megan White - Sr. Clinical Trials Specialist - Boston Scientific | LinkedIn
Clinical Studies - Boston Scientific
Boston Scientific announces positive stent results from clinical trial - Med-Tech Innovation
Boston Scientific Begins Clinical Trial To Evaluate New Pacing System in MRI Environment | DAIC
PINNACLE FLX Study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE
Nectero Medical Completes $19.5 Million Series C Financing Led by Boston Scientific - G-MedTech News Center
Boston Scientific Clinical Studies - Boston Scientific
Investigator-Sponsored Research Program - Boston Scientific
Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the Ranger™ Drug-Coated Balloon
Positive outcomes of Eluvia drug-eluting stent in IMPERIAL sub-analyses - Vascular News
Anti-Restenotic Drug Delivery with the AGENT Drug-Coated Balloon: Interview with Dr. Ian Meredith, Global CMO, Boston Scientific | Medgadget
Boston Scientific announces positive data from clinical trial for balloon catheter - Medical Plastics News
US Black Engineer & IT magazine - BOSTON SCIENTIFIC TO HOST HEALTH SERIES IN STEM CITY USA Career Communications Group (CCG) has announced that Boston Scientific Corporation will be hosting monthly “Healthy
Boston Scientific's Watchman FLX Meets 24-Month Secondary Efficacy Endpoint in PINNACLE FLX Trial - Cardiac Interventions Today
Boston Scientific cancer treatment shown to be effective in clinical trial | Worcester Business Journal
Bullet Point - Boston Scientific
